Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial.
Perez EA, Ballman KV, Mashadi-Hossein A, Tenner KS, Kachergus JM, Norton N, Necela BM, Carr JM, Ferree S, Perou CM, Baehner F, Cheang MC, Thompson EA.
Perez EA, et al. Among authors: ballman kv.
J Natl Cancer Inst. 2016 Oct 28;109(2):djw207. doi: 10.1093/jnci/djw207. Print 2017 Feb.
J Natl Cancer Inst. 2016.
PMID: 27794124
Free PMC article.
Clinical Trial.